Back to Search Start Over

Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer

Authors :
Groen, J.V.
Michiels, N.
Roessel, S. van
Besselink, M.G.
Bosscha, K.
Busch, O.R.
Dam, R. van
Eijck, C.H.J. van
Koerkamp, B.G.
Harst, E. van der
Hingh, I.H. de
Karsten, T.M.
Lips, D.J.
Meijer, V.E. de
Molenaar, I.Q.
Nieuwenhuijs, V.B.
Roos, D.
Santvoort, H.C. van
Wijsman, J.H.
Wit, F.
Zonderhuis, B.M.
Vos-Geelen, J. de
Wasser, M.N.
Bonsing, B.A.
Stommel, M.W.J.
Mieog, J.S.D.
Dutch Pancreatic Canc Grp
Surgery
MUMC+: MA Heelkunde (9)
RS: NUTRIM - R2 - Liver and digestive health
RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Epidemiologie
Interne Geneeskunde
MUMC+: MA Medische Oncologie (9)
Groningen Institute for Organ Transplantation (GIOT)
Center for Liver, Digestive and Metabolic Diseases (CLDM)
AGEM - Re-generation and cancer of the digestive system
CCA - Cancer Treatment and quality of life
CCA - Cancer Treatment and Quality of Life
AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
Source :
British Journal of Surgery, 109(1), 96-104. OXFORD UNIV PRESS, British Journal of Surgery, 109(1), 96-104. Wiley, British Journal of Surgery, 109, 1, pp. 96-104, The British journal of surgery, 109(1), 96-104. John Wiley & Sons Ltd., Groen, J V, Michiels, N, van Roessel, S, Besselink, M G, Bosscha, K, Busch, O R, van Dam, R, van Eijck, C H J, Koerkamp, B G, van der Harst, E, de Hingh, I H, Karsten, T M, Lips, D J, de Meijer, V E, Molenaar, I Q, Nieuwenhuijs, V B, Roos, D, van Santvoort, H C, Wijsman, J H, Wit, F, Zonderhuis, B M, de Vos-Geelen, J, Wasser, M N, Bonsing, B A, Stommel, M W J & Mieog, J S D 2022, ' Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer : Impact on short-And long-Term outcomes in a nationwide cohort analysis ', British Journal of Surgery, vol. 109, no. 1, pp. 96-104 . https://doi.org/10.1093/bjs/znab345, British Journal of Surgery, 109(1), 96-104. John Wiley and Sons Ltd, The British journal of surgery, 109(1), 96-104. John Wiley and Sons Ltd, British Journal of Surgery, 109, 96-104
Publication Year :
2022
Publisher :
John Wiley & Sons Ltd., 2022.

Abstract

Background Venous resection of the superior mesenteric or portal vein is increasingly performed in pancreatic cancer surgery, whereas results of studies on short- and long-term outcomes are contradictory. The aim of this study was to evaluate the impact of the type of venous resection in pancreatoduodenectomy for pancreatic cancer on postoperative morbidity and overall survival. Methods This nationwide retrospective cohort study included all patients who underwent pancreatoduodenectomy for pancreatic cancer in 18 centres (2013-2017). Results A total of 1311 patients were included, of whom 17 per cent underwent wedge resection and 10 per cent segmental resection. Patients with segmental resection had higher rates of major morbidity (39 versus 20 versus 23 per cent, respectively; P < 0.001) and portal or superior mesenteric vein thrombosis (18 versus 5 versus 1 per cent, respectively; P < 0.001) and worse overall survival (median 12 versus 16 versus 20 months, respectively; P < 0.001), compared to patients with wedge resection and those without venous resection. Multivariable analysis showed patients with segmental resection, but not those who had wedge resection, had higher rates of major morbidity (odds ratio = 1.93, 95 per cent c.i. 1.20 to 3.11) and worse overall survival (hazard ratio = 1.40, 95 per cent c.i. 1.10 to 1.78), compared to patients without venous resection. Among patients who received neoadjuvant therapy, there was no difference in overall survival among patients with segmental and wedge resection and those without venous resection (median 32 versus 25 versus 33 months, respectively; P = 0.470), although there was a difference in major morbidity rates (52 versus 19 versus 21 per cent, respectively; P = 0.012). Conclusion In pancreatic surgery, the short- and long-term outcomes are worse in patients with venous segmental resection, compared to patients with wedge resection and those without venous resection.Of 1311 patients who underwent pancreatoduodenectomy, 17 per cent underwent venous wedge resection and 10 per cent underwent venous segmental resection. Venous segmental, but not venous wedge, resection was associated with higher major morbidity rates (odds ratio = 1.93, 95 per cent c.i. 1.20 to 3.11) and worse overall survival (hazard ratio = 1.40, 95 per cent c.i. 1.10 to 1.78), compared to no venous resection. This nationwide study found worse short- and long-term outcomes in patients who had venous segmental resection. The results of this study urge the need for improving outcomes in patients who require venous segmental resection.

Details

Language :
English
ISSN :
13652168 and 00071323
Volume :
109
Issue :
1
Database :
OpenAIRE
Journal :
British Journal of Surgery
Accession number :
edsair.doi.dedup.....1f3bff60ff02c488933a318993881b3c
Full Text :
https://doi.org/10.1093/bjs/znab345